• 10:00AM

    Infertility care experts mark Veteran’s Day by helping military patients serving in New Jersey become parents

    (BASKING RIDGE – November 7, 2016)Reproductive Medicine Associates of New Jersey (RMANJ), a world-renowned leader in the field of infertility, today announced that their Helping Heroes Build Families program would continue into 2017 – its fifth year. Through the program, RMANJ has provided more than $250,000 worth of in vitro fertilization services at no cost since 2012.

    “With all they have sacrificed for our country, the founders and staff of RMANJ are deeply proud and passionate about giving back to those that protect our freedom. We are fortunate to be able to lend our expertise to help military families overcome the challenges of infertility,” said Dr. Richard Scott, MD, FACOG, ALD/HCLD, a founding partner and the laboratory director at RMANJ, and a former member of the U.S. Air Force.

    RMANJ introduced the Helping Heroes Build Families program to help address the financial difficulties our military heroes and their spouses face when trying to have a family. Earlier this year, the U.S. Defense Department announced limited fertility benefits for troops in the form of coverage for sperm and egg freezing. And recent Congressional legislation reportedly expands access to – but not funding for — some fertility services for veterans wounded in Iraq and Afghanistan. However, services such as IVF are still not covered for the majority of active-duty military members, putting such services out of reach for most servicemen and servicewomen.

    “Without Helping Heroes, we would have faced a financial burden – this program was a huge blessing,” said Monee Cullars, whose military husband was previously stationed at Fort Dix, NJ.

    “We can’t thank the team and the experienced staff at RMANJ enough,” added Monee. “They changed our life around. With my husband having to bear the loss of his parents at age 19, serving through three wars for this country, and later being told he would never have kids – our child meant the world. RMANJ has blessed us with a loving, beautiful and healthy child.”


    To be eligible for Helping Heroes Build Families, patients must:

    • Be active-duty United States Military Services personnel, or be the spouse of active-duty United States Military Service personnel in the United States Army, the United States Navy, the United States Air Force, the United States Marine Corps, or the United States Coast Guard;
    • Be currently serving on a U.S. military base or facility located in New Jersey
    • Have been properly screened and diagnosed in collaboration with MDL-based military healthcare providers.

    “Programs such as Helping Heroes will help fill the gap, but we urge our country’s leaders to do the right thing and mandate wider fertility service coverage for our active duty military members and their spouses,” said Thomas Molinaro, MD, MSCE, FACOG, from RMANJ’s Eatontown, NJ office.  “We have an obligation to support our military families – especially if their goal is to simply start a family.”

    For more information about eligibility and other program details, contact RMANJ at 973-871-1250 or visit


    The experts at RMANJ offer IVF delivery rates of 63.2 percent in women under 35 (n=886) and well above the US average*. Since 1999, they have helped bring nearly 40,000 babies to loving families. RMANJ has 25 physicians and 10 locations in New Jersey: Basking Ridge, Eatontown, Englewood, Freehold, Hamilton, Morristown, Somerset, Springfield, West Orange, and its newest location in Marlton, New Jersey. For more information, please call 973-656-2089 or visit

    RMANJ pioneered and successfully implemented a cutting-edge technology known as Select Comprehensive Chromosome Screening (SelectCCS) to more accurately detect healthy embryos that has led to successful pregnancies and ultimately healthy babies. SelectCCS is owned and operated by the Foundation for Embryonic Competence ( and offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.


    *SART 2014; Cumulative Outcome per Intended Retrieval; Preliminary Chance of Live Birth per Cycle. Please note: A comparison of clinic success rates may not be meaningful because a patient’s medical characteristics, treatment approaches and entrance criteria for assisted reproductive technology (ART) may vary from clinic to clinic. Visit to learn more.